APA
Drzymala R. E., Wasserman T. H., Won M., Shaw E., Cmelak A. J., Loeffler J. & Souhami L. (20080919). A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02). : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
Chicago
Drzymala R E, Wasserman T H, Won M, Shaw E, Cmelak A J, Loeffler J and Souhami L. 20080919. A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02). : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
Harvard
Drzymala R. E., Wasserman T. H., Won M., Shaw E., Cmelak A. J., Loeffler J. and Souhami L. (20080919). A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02). : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
MLA
Drzymala R E, Wasserman T H, Won M, Shaw E, Cmelak A J, Loeffler J and Souhami L. A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02). : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 20080919.